Past Global Health Events

The Academic Global Oncology Meeting, hosted by ASCO in collaboration with CGH, convened academic global oncology professionals and partners to discuss topics pertinent to strengthening the field of academic global oncology. This year's meeting drew on recommendations of the ASCO Academic Global Oncology Task Force, with participants discussing global oncology training, research, professional development, and partnerships.

CGH Director, Dr. Satish Gopal, presented the keynote address at the 2021 Virtual Cancer and Primary Care Research International (Ca-PRI) Network Conference. Dr. Gopal discussed global cancer research control in the context of the ongoing COVID-19 global pandemic.

NCI's Linsey Eldridge and Dr. David Berrigan presented their poster, "Structural Racism and Triple-Negative Breast Cancer Among Black and White Women in the United States" at the Society for Prevention Research annual meeting. Ms. Eldridge is from NCI's Center for Global Health and Dr. Berrigan is from NCI's Division of Cancer Control and Population Sciences.

Dr. Sudha Sivaram, CGH Program Director, joined speakers to discuss insights from the UICC network in North America on opportunities to engage in sustainable global cancer control activities.

This informational webinar highlighted the scope and focus of the funding initiative NOT-CA-21-058, Administrative Supplements to Stimulate and Strengthen Global Cancer Survivorship Research.

Epidemiologists Valerie McCormack, Ph.D. and Steady Chasimpha, MSc presented their research focused mostly on cancer epidemiology in sub-Saharan Africa, including on cancers contributing to excessive premature mortality in the region. This work included contextual studies of the reasons for low breast cancer survival as well as etiological research on esophageal cancer.

CGH hosted the Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries D43 (RFA-CA-20-031) informational webinar. The session highlighted the scope and focus of the program, provided information on funding opportunities, and answered questions from interested potential applicants.

The National Cancer Institute joined the governments of Ireland and Northern Ireland to strengthen cancer research, control, and training collaborations through the re-signing of the Memorandum of Understanding (MOU) of the Ireland-Northern Ireland-NCI Cancer Consortium. In addition to the signing of the MOU, the virtual event included discussion from cancer patients and experts on cancer care in Ireland.

This informational webinar on the Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health Funding Opportunity discussed the scope and focus of the program. This funding opportunity (RFA-CA-21-030) is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.

GCH convened the 9th Annual Symposium on Global Cancer Research as a virtual meeting alongside the Consortium of Universities for Global Health Annual Conference, March 10-11, 2021. The highly interactive two-day program explored the science and complex considerations around resilience and equity in global cancer research and control.